Notifications
Back
Notification settings
Back
More
Post notifications
Post reactions
Be notified when someone leaves a comment or a reply to your post or comment.
Updates and news
Stay ahead of important updates and news from the site.
Alarm
My account
Sign out
Home
About Us
About JNPMEDI
Team
History
Software
Professional Services
Professional Services
AWS MSP Service
Media
Careers
Close
JNPMEDI - Life Science RDC Company
Home
About Us
About JNPMEDI
Team
History
Software
Professional Services
Professional Services
AWS MSP Service
Media
Careers
Contact Us
Request for Quotation
JNPMEDI - Life Science RDC Company
Home
About Us
About JNPMEDI
Team
History
Software
Professional Services
Professional Services
AWS MSP Service
Media
Careers
Contact Us
Request for Quotation
EN
KR
EN
MENU
JNPMEDI - Life Science RDC Company
EN
KR
EN
Media
Stay up to date with the latest news from JNPMEDI
All
[News]
[Story]
[People]
Media
Stay up to date with the latest news from JNPMEDI
All
[News]
[Story]
[People]
Media
193
Search
Updates and news
[News]
JNPMEDI Participates in the 2023 American Drug Information Association
The JNPMEDI global team will be exhibiting its ‘Maven Clinical Cloud’ solution in the
0
0
JNPMEDI PR
20 Jun 2023
Views
990
Updates and news
[News]
JNPMEDI Participates in the 2023 American Society of Clinical Oncology (ASCO) Korean Pavilion Exhibition Booth
JNPMEDI, a company specializing in clinical trial data management solutions, has announced that it
0
0
JNPMEDI PR
1 Jun 2023
Views
983
Updates and news
[News]
"Streamlining Drug Safety Management with Digital Solutions" JNPMEDI Launches New Drug Safety Management Solution called 'Maven Safety’
| JNPMEDI Launches Drug Safety Management Solution 'Maven Safety' | Specializes in Collabora
0
0
JNPMEDI PR
31 May 2023
Views
995
Updates and news
[News]
Government to Foster 10,000 SaaS Companies by 2026: Spotlight on Industry-Specific SaaS Platforms Optimizing Innovative Services for Industrial Growth
| Government to Pursue Various Support Measures to Secure National Industrial Competitiveness, Aimin
0
0
JNPMEDI PR
23 May 2023
Views
985
Updates and news
[News]
Domestic Industry Unites to Propel South Korea to Global Pharma-Bio Superpower Status - Sharing Translation of FDA Guidelines and Analysis of Clinical Trends
| Domestic Industry Actively Engages in Multifaceted Activities to Solidify South Korea’s Stat
0
0
JNPMEDI PR
17 May 2023
Views
966
Updates and news
[News]
"New Growth Driver in Drug Development Market" Decentralized Clinical Trials (DCT) Triggered by COVID-19, Established a Firm Presence in the Clinical Trials Market
| Rising Need for Patient-Centered 'Decentralized Clinical Trials' Moving Away from Traditio
0
0
JNPMEDI PR
2 May 2023
Views
958
Updates and news
[News]
"Enhancing CRO Profitability through Digital Transformation" Attention to Domestic and International Digital Solutions for Reducing Clinical Trial Time and Costs
| Clinical Trial Industry Needs to Leverage DX to Secure Various Advantages such as Time and Cost Sa
0
0
JNPMEDI PR
25 Apr 2023
Views
968
Updates and news
[News]
JNPMEDI-WELT, Successfully Validates Digital Therapeutic 'WELT-I' through First DCT Clinical Trial in Korea
| 'WELT-I', the 2nd Domestic Digital Therapeutic, Gains Approval Through Validation Clinical
0
0
JNPMEDI PR
21 Apr 2023
Views
1225
Updates and news
[News]
JNPMEDI Signed an MOU with MediRama to Develop a Clinical Trial Solution for Anti-Cancer Drugs.
JNPMEDI announced on March 22nd that it had signed an MOU with MediRama for the development of cli
0
0
JNPMEDI PR
22 Mar 2023
Views
1045
Previous
10
11
12
13
14
15
16
17
18
Next
